CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 5, 2008, Pages 1120-1126

  Lee, Kyoung Mu ^a,g   Kang, Daehee ^a,b   Clapper, Margie L ^c   Ingelman Sundberg, Magnus ^d   Ono Kihara, Masko ^e   Kiyohara, Chikako ^f   Min, Shen ^g   Lan, Qing ^g   Le Marchand, Loic ^h   Lin, Pinpin ⁱ   Li Lung, Maria ^j   Pinarbasi, Hatice ^k   Pisani, Paola ^l   Srivatanakul, Petcharin ^m   Seow, Adeline ⁿ   Sugimura, Haruhiko ^o   Tokudome, Shinkan ^p   Yokota, Jun ^q   Taioli, Emanuela ^r  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c FOX CHASE CANCER CENTER   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY OF HAWAII CANCER CENTER   (United States)

ⁱ NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^j HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^k CUMHURIYET UNIVERSITY   (Turkey)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m NATIONAL CANCER INSTITUTE   (Thailand)

ⁿ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^o HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^p NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^q NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^r UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; ASIA; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENETIC SUSCEPTIBILITY; HUMAN; LUNG CANCER; MALE; PRIORITY JOURNAL; ASIAN; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; LUNG TUMOR; MIDDLE AGED; RISK; SMOKING; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; SMOKING;

EID: 52649148138     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2786     Document Type: Article

References (43)

1. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 2002;3:461-9.
2. Petersen DD, McKinney CE, Ikeya K, et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 1991;48:720-5.
3. Landi MT, Bertazzi PA, Shields PG, et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 1994;4:242-6.
4. Kiyohara C, Hirohata T, Inutsuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res 1996;87:18-24.
5. Vineis P, Veglia F, Benhamou S, et al. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 2003;104:650-7.
6. Le Marchand L, Guo C, Benhamou S, et al. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 2003;14:339-46.
7. Houlston RS. CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics 2000;10:105-14.
8. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione -S-transferase family of enzymes. Mutat Res 2001;482:21-6.
9. Brockmöller J, Cascorbi I, Kerb R, Sachse C, Roots I. Polymorphisms in xenobiotic conjugation and disease predisposition. Toxicol Lett 1998;102-3:173-83.
10. Cuzick J. Interaction, subgroup analysis and sample size. In: Vineis P, Malats N, Lang M, et al., editors. Metabolic polymorphisms and susceptibility to cancer. Lyon: IARC Scientific Publication; 1999. p. 109-21.
11. Ye Z, Song H, Higgins JP, Pharoah P, Danesh J. Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 2006;3:e91.
12. Benhamou S, Lee WJ, Alexandrie AK, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 2002;23:1343-50. Erratum in: Carcinogenesis 2002;23:1771.
13. Raimondi S, Paracchini V, Autrup H, et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006;164:1027-42.
14. Taioli E. International collaborative study on genetic susceptibility to environmental carcinogens. Cancer Epidemiol Biomarkers Prev 1999;8:727-8.
15. Kihara M, Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995;16:2331-6.
16. Ge H, Lam WK, Lee J, Wong MP, Yew WW, Lung ML. Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma patients. Lung Cancer 1996;15:355-66.
17. Sugimura H, Wakai K, Genka K, et al. Association of Ile462Val (exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. Cancer Epidemiol Biomarkers Prev 1998;7:413-7.
18. Persson I, Johansson I, Lou YC, et al. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer 1999;81:325-9.
19. Le Marchand L, Sivaraman L, Pierce L, et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 1998;58:4858-63.
20. Kiyohara C, Nakanishi Y, Inutsuka S, et al. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics 1998;8:315-23.
21. Kiyohara C, Yamamura KI, Nakanishi Y, Takayama K, Hara N. Polymorphism in GSTM1, GSTT1, and GSTP1 and susceptibility to lung cancer in a Japanese population. Asian Pac J Cancer Prev 2000;1:293-8.
22. Lan Q, He X, Costa DJ, et al. Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol Biomarkers Prev 2000;9:605-8.
23. Yin L, Pu Y, Liu TY, Tung YH, Chen KW, Lin P. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer 2001;33:133-41.
24. Zhao B, Seow A, Lee EJ, et al. Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 2001;10:1063-7.
25. Sunaga N, Kohno T, Yanagitani N, et al. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 2002;11:730-8.
26. Wang J, Deng Y, Cheng J, Ding J, Tokudome S. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 2003;201:185-93.
27. Lee KM, Kang D, Lee SJ, et al. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea. Oncol Rep 2006;16:1035-9.
28. Pisani P, Srivatanakul P, Randerson-Moor J, et al. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand. Cancer Epidemiol Biomarkers Prev 2006;15:667-74.
29. Dresler CM, Fratelli C, Babb J, Everley L, Evans AA, Clapper ML. Gender differences in genetic susceptibility for lung cancer. Lung Cancer 2000;30:153-60.
30. Pinarbasi H, Silig Y, Cetinkaya O, et al. Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. Cancer Genet Cytogenet 2003;146:125-9.
31. Taioli E, Zocchetti C, Garte S. Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Environ Health Perspect 1998;106:67-70.
32. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-48.
33. Wydner EL, Hoffman D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res 1994;54:5284-95.
34. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993;14:1479-81.
35. Saarikoski ST, Voho A, Reinikainen M, et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 1998;77:516-21.
36. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996;274:430-2.
37. Greenblatt MS, BennettWP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78.
38. Mooney LA, Santella RM, Covey L, et al. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol Biomarkers Prev 1995;4:627-34.
39. Mollerup S, Berge G, Baera R, et al. Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer 2006;119:741-4.
40. Alexandrov K, Cascorbi I, Rojas M, Bouvier G, Krief E, Bartsch H. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis 2002;23:1969-77.
41. Butkiewicz D, Cole KJ, Phillips DH, Harris CC, Chorazy M. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. Eur J Cancer Prev 1999;8:315-23.
42. Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem 1995;22:195-209.
43. London SJ, Yuan JM, Chung FL, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 2000;356:724-9. Erratum in: Lancet 2000;356:2104.